CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+16.06%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.88B
AUM Growth
+$7.88B
(+14%)
Cap. Flow
-$29.8M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
72.68%
Holding
127
New
5
Increased
27
Reduced
38
Closed
14
Top Buys
| 1 |
Microsoft
MSFT
|
$371M |
| 2 |
LivaNova
LIVN
|
$8.09M |
| 3 |
Takeda Pharmaceutical
TAK
|
$7.46M |
| 4 |
Centene
CNC
|
$4.97M |
| 5 |
Illumina
ILMN
|
$4.51M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$330M |
| 2 |
Visa
V
|
$16.7M |
| 3 |
HDFC Bank
HDB
|
$10.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$9.85M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$8.53M |
Sector Composition
| 1 | Financials | 22.43% |
| 2 | Consumer Discretionary | 16.91% |
| 3 | Healthcare | 14.47% |
| 4 | Consumer Staples | 10.11% |
| 5 | Communication Services | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Merck
MRK
$210B
| $27.4M | 0.35% | 329,955 | – | – |
|
|
BHVN
27
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $19.6M | 0.25% | 381,751 +83,001 | +28% | +$4.27M |
|
|
AMRN
28
Amarin Corp
AMRN
$311M
| $15.8M | 0.2% | 761,329 +128,463 | +20% | +$2.67M |
|
29
Amgen
AMGN
$155B
| $15.3M | 0.19% | 80,787 -29,929 | -27% | -$5.69M |
|
30
HCA Healthcare
HCA
$94.5B
| $14.7M | 0.19% | 112,905 +20,178 | +22% | +$2.63M |
|
31
Boston Scientific
BSX
$156B
| $14.1M | 0.18% | 367,194 | – | – |
|
32
Becton Dickinson
BDX
$55.3B
| $13.2M | 0.17% | 52,955 | – | – |
|
33
Gilead Sciences
GILD
$140B
| $12.8M | 0.16% | 196,598 -11,093 | -5% | -$721K |
|
34
Vertex Pharmaceuticals
VRTX
$100B
| $12.6M | 0.16% | 68,557 -4,780 | -7% | -$879K |
|
35
Eli Lilly
LLY
$657B
| $11.9M | 0.15% | 91,848 | – | – |
|
|
AGN
36
DELISTED
Allergan plc
AGN
| $11.1M | 0.14% | 75,890 | – | – |
|
37
AbbVie
ABBV
$372B
| $10.1M | 0.13% | 125,780 | – | – |
|
|
38
Centene
CNC
$14.3B
| $9.95M | 0.13% | 187,306 +93,653 | +100% | +$4.97M |
|
39
Biogen
BIIB
$19.4B
| $9.82M | 0.12% | 41,551 -2,614 | -6% | -$618K |
|
40
Hologic
HOLX
$14.9B
| $9.65M | 0.12% | 199,328 | – | – |
|
|
CELG
41
DELISTED
Celgene Corp
CELG
| $9.24M | 0.12% | 97,986 -28,564 | -23% | -$2.69M |
|
42
Edwards Lifesciences
EW
$47.8B
| $8.79M | 0.11% | 45,943 | – | – |
|
|
43
LivaNova
LIVN
$3.08B
| $8.09M | 0.1% | +83,163 | New | +$8.09M |
|
44
Intuitive Surgical
ISRG
$170B
| $7.5M | 0.1% | 13,137 +7,665 | +140% | +$4.37M |
|
|
45
Takeda Pharmaceutical
TAK
$47.3B
| $7.46M | 0.09% | +366,380 | New | +$7.46M |
|
46
Viatris
VTRS
$12.3B
| $7.3M | 0.09% | 257,473 | – | – |
|
|
AERI
47
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $6.47M | 0.08% | 136,142 +55,127 | +68% | +$2.62M |
|
|
ALXN
48
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.4M | 0.08% | 47,325 -4,275 | -8% | -$578K |
|
49
Heron Therapeutics
HRTX
$207M
| $6.16M | 0.08% | 252,069 +120,471 | +92% | +$2.94M |
|
50
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.12M | 0.08% | 68,851 | – | – |
|